800 related articles for article (PubMed ID: 19409439)
1. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits.
Jeng W; Wong AW; Ting-A-Kee R; Wells PG
Free Radic Biol Med; 2005 Aug; 39(3):317-26. PubMed ID: 15993330
[TBL] [Abstract][Full Text] [Related]
3. Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats.
Sae-Ung K; Uéda K; Govitrapong P; Phansuwan-Pujito P
J Pineal Res; 2012 Jan; 52(1):128-37. PubMed ID: 21851386
[TBL] [Abstract][Full Text] [Related]
4. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
6. Prenatal exposure to methamphetamine in the rat: ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons.
Gomes-da-Silva J; Pérez-Rosado A; de Miguel R; Fernández-Ruiz J; Silva MC; Tavares MA
Ann N Y Acad Sci; 2002 Jun; 965():68-77. PubMed ID: 12105086
[TBL] [Abstract][Full Text] [Related]
7. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of methamphetamine-induced neurochemical deficits by melatonin.
Gibb JW; Bush L; Hanson GR
J Pharmacol Exp Ther; 1997 Nov; 283(2):630-5. PubMed ID: 9353379
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine-induced changes in dopamine receptors in early postnatal rat brain.
Mukda S; Kaewsuk S; Ebadi M; Govitrapong P
Dev Neurosci; 2009; 31(3):193-201. PubMed ID: 19145071
[TBL] [Abstract][Full Text] [Related]
10. Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines.
Tocharus J; Khonthun C; Chongthammakun S; Govitrapong P
J Pineal Res; 2010 May; 48(4):347-52. PubMed ID: 20374443
[TBL] [Abstract][Full Text] [Related]
11. Persistent alterations in regional brain glial fibrillary acidic protein and synaptophysin levels following pre- and postnatal polychlorinated biphenyl exposure.
Morse DC; Plug A; Wesseling W; van den Berg KJ; Brouwer A
Toxicol Appl Pharmacol; 1996 Aug; 139(2):252-61. PubMed ID: 8806841
[TBL] [Abstract][Full Text] [Related]
12. Effects of neonatal exposure to methamphetamine: catecholamine levels in brain areas of the developing rat.
Gomes-da-Silva J; de Miguel R; Fernández-Ruiz J; Summavielle T; Tavares MA
Ann N Y Acad Sci; 2004 Oct; 1025():602-11. PubMed ID: 15542769
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
Suemaru J; Akiyama K; Tanabe Y; Kuroda S
Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
[TBL] [Abstract][Full Text] [Related]
14. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.
He J; Yang Y; Yu Y; Li X; Li XM
Behav Brain Res; 2006 Sep; 172(1):39-45. PubMed ID: 16712969
[TBL] [Abstract][Full Text] [Related]
15. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species.
Tsao LI; Ladenheim B; Andrews AM; Chiueh CC; Cadet JL; Su TP
J Pharmacol Exp Ther; 1998 Oct; 287(1):322-31. PubMed ID: 9765353
[TBL] [Abstract][Full Text] [Related]
16. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
Kitamura O
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
Narita M; Miyatake M; Shibasaki M; Tsuda M; Koizumi S; Narita M; Yajima Y; Inoue K; Suzuki T
J Neurochem; 2005 Jun; 93(6):1383-92. PubMed ID: 15935054
[TBL] [Abstract][Full Text] [Related]
18. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
[TBL] [Abstract][Full Text] [Related]
20. Effects of prenatal exposure to methamphetamine on the development of the rat retina.
Melo P; Rodrigues LG; Silva MC; Tavares MA
Ann N Y Acad Sci; 2006 Aug; 1074():590-603. PubMed ID: 17105955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
